Yes you can be rejected because one of your earlier patents covers the same invention. If that happens it is not a bad thing.
The basic problem when you submit a patent is you don’t know what claims will make it through the patent process. It can make sense to submit two similar patents applications and see what sticks after the process. More than once patent claim has been blocked on one patent, but granted on another patent processed by a different examiner. Such is the wonders of the patent system.
- Forums
- ASX - By Stock
- RAC
- Ann: Zantrene highly effective in Melanoma preclinical study
Ann: Zantrene highly effective in Melanoma preclinical study, page-177
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.47 |
Change
-0.055(3.61%) |
Mkt cap ! $250.5M |
Open | High | Low | Value | Volume |
$1.53 | $1.58 | $1.46 | $143.9K | 96.36K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 230 | $1.47 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.48 | 550 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 230 | 1.465 |
1 | 410 | 1.460 |
3 | 46800 | 1.450 |
2 | 25548 | 1.440 |
1 | 2046 | 1.420 |
Price($) | Vol. | No. |
---|---|---|
1.480 | 550 | 1 |
1.490 | 2470 | 1 |
1.535 | 2456 | 2 |
1.570 | 37690 | 1 |
1.575 | 2000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online